Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.400
-0.040 (-2.78%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Organigram Global Revenue
Organigram Global had revenue of 63.54M CAD in the quarter ending December 31, 2025, with 48.70% growth. This brings the company's revenue in the last twelve months to 279.99M, up 68.55% year-over-year. In the fiscal year ending September 30, 2025, Organigram Global had annual revenue of 259.18M with 62.15% growth.
Revenue (ttm)
279.99M CAD
Revenue Growth
+68.55%
P/S Ratio
0.97
Revenue / Employee
246,254 CAD
Employees
1,137
Market Cap
197.42M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 259.18M | 99.34M | 62.15% |
| Sep 30, 2024 | 159.84M | 10.64M | 7.13% |
| Sep 30, 2023 | 149.21M | 3.40M | 2.33% |
| Aug 31, 2022 | 145.81M | 66.65M | 84.19% |
| Aug 31, 2021 | 79.16M | -7.63M | -8.79% |
| Aug 31, 2020 | Pro | Pro | Pro |
| Aug 31, 2019 | Pro | Pro | Pro |
| Aug 31, 2018 | Pro | Pro | Pro |
| Aug 31, 2017 | Pro | Pro | Pro |
| Aug 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Organogenesis Holdings | 564.17M |
| Evolus | 297.18M |
| Aurora Cannabis | 272.13M |
| Akebia Therapeutics | 236.20M |
| Lifecore Biomedical | 129.46M |
| Assertio Holdings | 118.71M |
| Anika Therapeutics | 112.82M |
| SIGA Technologies | 94.57M |
OGI News
- 13 days ago - Organigram (OGI) Completes Acquisition of Sanity Group - GuruFocus
- 13 days ago - Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities - Business Wire
- 4 weeks ago - Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting - Business Wire
- 5 weeks ago - Organigram (OGI) Gains Support for Sanity Group Acquisition - GuruFocus
- 5 weeks ago - Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH - Business Wire
- 7 weeks ago - Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting - Business Wire
- 7 weeks ago - Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity - Business Wire
- 2 months ago - 3 Canadian Marijuana Stocks To Diversify Your Stock Portfolio - MarijuanaStocks